Digitala Vetenskapliga Arkivet

Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Bacteriophage-based strategies for biocontrol and treatment of infectious diseases
Phenikaa Univ, Vietnam.
KTH Royal Inst Technol, Sweden.
Vinayaka Missions Res Fdn Univ, India.
MGS Univ, India.
Show others and affiliations
2025 (English)In: Computational and Structural Biotechnology Journal, E-ISSN 2001-0370, Vol. 27, p. 2924-2932Article, review/survey (Refereed) Published
Abstract [en]

Bacteriophages are viruses that infect bacteria, which are essential for controlling bacterial diversity. Among the novel aspects, phage display-based strategies are used for epitope mapping and the development of immunotherapy. A recent classification system has been developed based on the recent sequencing methods and bioinformatic tools. The unique specificity of phages is of increasing use in biocontrol, where bacteriophages are applied to target and reduce harmful bacterial populations in agriculture, food preservation and safety, offering a sustainable alternative to chemical exposure and a plausible solution to excessive misuse of antibiotics. Phage therapy has emerged as a complement to antibiotics for difficult-to-treat infectious diseases such as multi-drug resistant bacteria where other alternatives are lacking. The ability of bacteriophages to specifically target pathogenic bacteria while sparing the normal flora makes them attractive treatment options. Among the challenges are the slow uptake of phage therapy in the clinical setting, a lack of standardisation and regulatory issues. Nevertheless, phage-based strategies are likely to become a future cornerstone for biocontrol and treatment of infectious diseases.

Place, publisher, year, edition, pages
ELSEVIER , 2025. Vol. 27, p. 2924-2932
Keywords [en]
Bacteriophage; Antimicrobial resistance; Biocontrol; Phage therapy and antibiotic
National Category
Pharmaceutical Sciences
Identifiers
URN: urn:nbn:se:liu:diva-216912DOI: 10.1016/j.csbj.2025.06.046ISI: 001527996600001PubMedID: 40677245Scopus ID: 2-s2.0-105009722154OAI: oai:DiVA.org:liu-216912DiVA, id: diva2:1992683
Available from: 2025-08-28 Created: 2025-08-28 Last updated: 2026-01-16

Open Access in DiVA

fulltext(2821 kB)88 downloads
File information
File name FULLTEXT01.pdfFile size 2821 kBChecksum SHA-512
11186cadec1c94af87203a8c98e61279b3969bc3fd6716b2c70219d6f85cb57df8c028ade12bca9f29a21e081738bd38303ac3484ae30aadbb49d825fda332ee
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMedScopus

Search in DiVA

By author/editor
Schön, ThomasKumar, Rajender
By organisation
Division of Inflammation and InfectionFaculty of Medicine and Health SciencesDepartment of Infectious Diseases
In the same journal
Computational and Structural Biotechnology Journal
Pharmaceutical Sciences

Search outside of DiVA

GoogleGoogle Scholar
Total: 88 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 54 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf